Macrogenics (MGNX) Net Margin (2012 - 2026)

Macrogenics (MGNX) reported Net Margin of 184.49% for Q1 2026, up 13930.0% year-over-year from N/an in Q1 2025, and down 438.4% quarter-over-quarter from 34.27% in Q4 2025.

Macrogenics (MGNX) Net Margin (2012 - 2026) Analysis & Trends

Macrogenics (MGNX) has 15 years of Net Margin data on file, last reported at 184.49% in Q1 2026.

  • Net Margin for Q1 2026 came in at 184.49%, up 13930.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 45.76% (down 1138.0% YoY), and the FY2025 annual result was 49.89%, down 524.0% from the prior year.
  • Net Margin retreated to 184.49% in Q1 2026 per MGNX's latest filing, from 34.27% in the prior quarter.
  • Over five years, Net Margin peaked at 50.86% in Q3 2024 and troughed at 1686.79% in Q2 2024.
  • A 5-year average of 298.46% and a median of 162.99% in 2025 frame the typical range for Net Margin.
  • The sharpest annual moves came in 2024 and 2025: Net Margin tumbled 133861 bps in 2024, then surged 152380 bps in 2025.
  • A 5-year view of Net Margin shows it stood at 16.39% in 2022, then sank by 2908 bps to 460.39% in 2023, then jumped by 92 bps to 38.55% in 2024, then increased by 11 bps to 34.27% in 2025, then sank by 438 bps to 184.49% in 2026.
  • Business Quant data shows MGNX's Net Margin at 184.49% in Q1 2026, 34.27% in Q4 2025, and 23.09% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.82%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 34.53%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Macrogenics 260.14 Mn 193.63 Mn - -184.49%

Historic Data

Download Data
DateValue
Mar 31, 2026 -184.49%
Dec 31, 2025 -34.27%
Sep 30, 2025 23.09%
Jun 30, 2025 -162.99%
Mar 31, 2025 -323.79%
Dec 31, 2024 -38.55%
Sep 30, 2024 50.86%
Jun 30, 2024 -1,686.79%
Mar 31, 2024 -602.84%
Dec 31, 2023 -460.39%
Sep 30, 2023 -341.46%
Jun 30, 2023 -348.17%
Mar 31, 2023 -159.54%
Dec 31, 2022 16.39%
Sep 30, 2022 -59.80%
Jun 30, 2022 -160.76%
Mar 31, 2022 -600.29%
Dec 31, 2021 -411.65%
Sep 30, 2021 -338.32%
Jun 30, 2021 -130.96%